Structural brain alterations following adult non-CNS cancers: a systematic review of the neuroimaging literature

References

• Bernstein LJ, McCreath GA, Komeylian Z, et al. Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: a multilevel meta-analysis. Neurosci Biobehav Rev. 2017;83:417–428.
   PubMed Web of Science ®Google Scholar
• Lange M, Giffard B, Noal S, et al. Baseline cognitive functions among elderly patients with localised breast cancer. Eur J Cancer. 2014;50:2181–2189.
   PubMed Web of Science ®Google Scholar
• Cleeland CS, Bennett GJ, Dantzer R, et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer. 2003;97:2919–2925.
   PubMed Web of Science ®Google Scholar
• Irwin M. Why sleep is important for health: a psychoneuroimmunology perspective. Annu Rev Psychol. 2015;66:143–172.
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser JK, Derry HM, Fagundes CP. Inflammation: depression fans the flames and feasts on the heat. Am J Psychiatry. 2015;172:1075–1091.
   PubMed Web of Science ®Google Scholar
• Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications [Internet]. Pharmacol Ther. 2011;130:226–238.
   PubMed Web of Science ®Google Scholar
• Innominato PF, Roche VP, Palesh OG, et al. The circadian timing system in clinical oncology. Ann Med. 2014;46:191–207.
   PubMed Web of Science ®Google Scholar
• Mandelblatt JS, Hurria A, McDonald BC, et al. Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know? Semin Oncol. 2013;40:709–725.
   PubMed Web of Science ®Google Scholar
• Lomeli N, Di K, Czerniawski J, et al. Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats. Free Radic Biol Med. 2017;102:274–286.
   PubMed Web of Science ®Google Scholar
• Wang XM, Walitt B, Saligan L, et al. Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy [Internet]. Cytokine. 2015;72:86–96.
   PubMed Web of Science ®Google Scholar
• Castel H, Denouel A, Lange M, et al. Biomarkers associated with cognitive impairment in treated cancer patients: potential predisposition and risk factors. Front Pharmacol. 2017;8:138.
   PubMed Web of Science ®Google Scholar
• Ashburner J, Friston KJ. Voxel-based morphometry – the methods. Neuroimage. 2000;11:805–821.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar
• Stouten-Kemperman MM, de Ruiter MB, Koppelmans V, et al. Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type. Brain Imaging Behav. 2015;9:275–284.
   PubMed Web of Science ®Google Scholar
• Billiet T, Emsell L, Vandenbulcke M, et al. Recovery from chemotherapy-induced white matter changes in young breast cancer survivors? Brain Imaging Behav. 2018;12:64–77.
   PubMed Web of Science ®Google Scholar
• Sato C, Sekiguchi A, Kawai M, et al. Postoperative structural brain changes and cognitive dysfunction in patients with breast cancer. Chen K, editor. PLoS One. 2015;10:e0140655.
   PubMed Web of Science ®Google Scholar
• Koppelmans V, de Groot M, de Ruiter MB, et al. Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy. Hum Brain Mapp. 2014;35:889–899.
   PubMed Web of Science ®Google Scholar
• Lepage C, Smith AM, Moreau J, et al. A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients. Springerplus. 2014;3:444.
   PubMedGoogle Scholar
• Conroy SK, McDonald BC, Smith DJ, et al. Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast Cancer Res Treat. 2013;7(4):493–502.
   Web of Science ®Google Scholar
• McDonald BC, Conroy SK, Smith DJ, et al. Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain Behav Immun. 2013;30:S117–S125.
   PubMed Web of Science ®Google Scholar
• Deprez S, Amant F, Smeets A, et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. JCO. 2012;30:274–281.
   PubMed Web of Science ®Google Scholar
• De Ruiter MB, Reneman L, Boogerd W, et al. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp. 2012;33:2971–2983.
   PubMed Web of Science ®Google Scholar
• Hosseini SMH, Koovakkattu D, Kesler SR. Altered small-world properties of gray matter networks in breast cancer. BMC Neurol. 2012;12:28.
   PubMed Web of Science ®Google Scholar
• Koppelmans V, de Ruiter MB, van der Lijn F, et al. Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat. 2012;132:1099–1106.
   PubMed Web of Science ®Google Scholar
• Scherling C, Collins B, MacKenzie J, et al. Structural brain differences in breast cancer patients compared to matched controls prior to chemotherapy. Int J Biol. 2012;4:p3.
   Google Scholar
• Chen BT, Sethi SK, Jin T, et al. Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study. Breast Cancer Res. 2018;20:38.
   PubMed Web of Science ®Google Scholar
• Bergouignan L, Lefranc JP, Chupin M, et al. Breast cancer affects both the hippocampus volume and the episodic autobiographical memory retrieval. PLoS One. 2011;6:e25349.
   PubMed Web of Science ®Google Scholar
• Deprez S, Amant F, Yigit R, et al. Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp. 2011;32:480–493.
   PubMed Web of Science ®Google Scholar
• McDonald BC, Conroy SK, Ahles TA, et al. Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat. 2010;123:819–828.
   PubMed Web of Science ®Google Scholar
• Inagaki M, Yoshikawa E, Matsuoka Y, et al. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer. 2007;109:146–156.
   PubMed Web of Science ®Google Scholar
• Abraham J, Haut MW, Moran MT, et al. Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging. Clin Breast Cancer. 2008;8:88–91.
   PubMed Web of Science ®Google Scholar
• Yoshikawa E, Matsuoka Y, Inagaki M, et al. No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors. Breast Cancer Res Treat. 2005;92:81–84.
   PubMed Web of Science ®Google Scholar
• Eberling JL, Wu C, Tong-Turnbeaugh R, et al. Estrogen- and tamoxifen-associated effects on brain structure and function. Neuroimage. 2004;21:364–371.
   PubMed Web of Science ®Google Scholar
• Kesler S, Janelsins M, Koovakkattu D, et al. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun. 2013;30:S109–S116.
   PubMed Web of Science ®Google Scholar
• Menning S, de Ruiter MB, Veltman DJ, et al. Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study. Brain Imaging Behav. 2018;12:324–334.
   PubMed Web of Science ®Google Scholar
• Apple AC, Ryals AJ, Alpert KI, et al. Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns. NeuroImage Clin. 2017;14:685–691.
   PubMed Web of Science ®Google Scholar
• Kesler SR, Adams M, Packer M, et al. Disrupted brain network functional dynamics and hyper-correlation of structural and functional connectome topology in patients with breast cancer prior to treatment. Brain Behav. 2017;7:e00643.
   PubMed Web of Science ®Google Scholar
• Mo C, Lin H, Fu F, et al. Chemotherapy-induced changes of cerebral activity in resting-state functional magnetic resonance imaging and cerebral white matter in diffusion tensor imaging. Oncotarget. 2017;8:81273–81284.
   PubMedGoogle Scholar
• Kesler SR, Watson CL, Blayney DW. Brain network alterations and vulnerability to simulated neurodegeneration in breast cancer. Neurobiol Aging. 2015;36:2429–2442.
   PubMed Web of Science ®Google Scholar
• Koppelmans V, Vernooij MW, Boogerd W, et al. Prevalence of cerebral small-vessel disease in long-term breast cancer survivors exposed to both adjuvant radiotherapy and chemotherapy. JCO. 2015;33:588–593.
   PubMed Web of Science ®Google Scholar
• Menning S, de Ruiter MB, Veltman DJ, et al. Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment—the role of fatigue. NeuroImage Clin. 2015;7:547–554.
   PubMed Web of Science ®Google Scholar
• Amidi A, Hosseini SMH, Leemans A, et al. Changes in brain structural networks and cognitive functions in testicular cancer patients receiving cisplatin-based chemotherapy. J Natl Cancer Inst. 2017;109:9041–9044.
   Google Scholar
• Stouten-Kemperman MM, de Ruiter MB, Caan MWA, et al. Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy. Hum Brain Mapp. 2015;36:4638–4647.
   PubMed Web of Science ®Google Scholar
• Amidi A, Agerbaek M, Wu LM, et al. Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment. Brain Imaging Behav. 2017;11:769–783.
   PubMed Web of Science ®Google Scholar
• Correa DD, Wang Y, West JD, et al. Prospective assessment of white matter integrity in adult stem cell transplant recipients. Brain Imaging Behav. 2016;10:486–496.
   PubMed Web of Science ®Google Scholar
• Correa DD, Root JC, Baser R, et al. A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients. Brain Imaging Behav. 2013;7:478–490.
   PubMed Web of Science ®Google Scholar
• Simó M, Root JC, Vaquero L, et al. Cognitive and brain structural changes in a lung cancer population. J Thorac Oncol. 2015;10:38–45.
   PubMed Web of Science ®Google Scholar
• Chao HH, Hu S, Ide JS, et al. Effects of androgen deprivation on cerebral morphometry in prostate cancer patients – an exploratory study. Wilson E, editor. PLoS One. 2013;8:e72032.
   PubMed Web of Science ®Google Scholar
• Correa DD, Root JC, Kryza-Lacombe M, et al. Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: a pilot study. Brain Imaging Behav. 2017;11:1652–1663.
   PubMed Web of Science ®Google Scholar
• Hatzimichael E, Tuthill M. Hematopoietic stem cell transplantation. Stem Cells Cloning Adv Appl. 2010; 3:105–117.
   PubMedGoogle Scholar
• Hsu JL, Chen YL, Leu JG, et al. Microstructural white matter abnormalities in type 2 diabetes mellitus: a diffusion tensor imaging study. Neuroimage. 2012;59:1098–1105.
   PubMed Web of Science ®Google Scholar
• Alexander AL, Lee JE, Lazar M, et al. Diffusion tensor imaging of the brain. Neurotherapeutics. 2007;4:316–329.
   PubMed Web of Science ®Google Scholar
• Deprez S, Kesler SR, Saykin AJ, et al. International cognition and cancer task force recommendations for neuroimaging methods in the study of cognitive impairment in non-CNS cancer patients. J Natl Cancer Inst. 2018;110:223–231.
   PubMedGoogle Scholar
• Takeuchi H, Taki Y, Nouchi R, et al. Global associations between regional gray matter volume and diverse complex cognitive functions: evidence from a large sample study. Sci Rep. 2017;7:10014.
   PubMed Web of Science ®Google Scholar
• General Assembly of the World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014;81:14–18.
   PubMedGoogle Scholar